Bay Street News, 2024

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and […]

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s […]

Hosts conference call on Thursday, February 15, 2024 NEW YORK and KUALA LUMPUR, Malaysia, Jan. 31, 2024 (GLOBE NEWSWIRE) — […]

TORONTO, Jan. 31, 2024 (GLOBE NEWSWIRE) — VVC Exploration Corporation, dba VVC Resources, (“VVC”) or (the “Company”), (TSX-V:VVC and OTCQC:VVCVF) […]

DALLAS, Jan. 31, 2024 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. (NYSE:WHG) will release its fourth quarter and fiscal year 2023 […]

PARIS, Jan. 31, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) will host a conference call and webcast on Wednesday, February […]

NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to provide […]

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company […]

WESTLAKE VILLAGE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing […]

FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing […]